Let’s start up with the current stock price of Synthetic Biologics Inc. (SYN), which is $0.64 to be very precise. The Stock rose vividly during the last session to $0.62 after opening rate of $0.61 while the lowest price it went was recorded $0.58 before closing at $0.61.
Recently in News on June 30, 2020, Synthetic Biologics Announces Submission of IND Application to U.S. FDA for SYN-020 Intestinal Alkaline Phosphatase. — Initial Indication Will Seek to Reduce Acute Intestinal Side Effects Associated with Radiation Therapy in Cancer Patients –. You can read further details here
Synthetic Biologics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.7500 on 07/30/20, with the lowest value was $0.2522 for the same time period, recorded on 03/19/20.
Synthetic Biologics Inc. (SYN) full year performance was 41.63%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Synthetic Biologics Inc. shares are logging -14.17% during the 52-week period from high price, and 155.23% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.25 and $0.75.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 920767 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Synthetic Biologics Inc. (SYN) recorded performance in the market was 20.54%, having the revenues showcasing 49.87% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 11.40M, as it employees total of 11 workers.
Market experts do have their say about Synthetic Biologics Inc. (SYN)
During the last month, 0 analysts gave the Synthetic Biologics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.4574, with a change in the price was noted +0.3199. In a similar fashion, Synthetic Biologics Inc. posted a movement of +103.16% for the period of last 100 days, recording 528,246 in trading volumes.
Technical breakdown of Synthetic Biologics Inc. (SYN)
Raw Stochastic average of Synthetic Biologics Inc. in the period of last 50 days is set at 60.00%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 85.71%. In the last 20 days, the company’s Stochastic %K was 75.29% and its Stochastic %D was recorded 58.35%.
Bearing in mind the latest performance of Synthetic Biologics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 20.54%. Additionally, trading for the stock in the period of the last six months notably improved by 38.86%, alongside a boost of 41.63% for the period of the last 12 months. The shares increased approximately by 32.19% in the 7-day charts and went up by -13.99% in the period of the last 30 days. Common stock shares were driven by 49.87% during last recorded quarter.